References
1. Shapiro LE, Surks MI. Hypothyroidism, in Becker KL (ed):Principles and Practice of Endocrinology and metabolism. Philadelphia, Lippincott, Williams, and Wilkins, 2001, ed 3, 445–454.
2. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001;345:260–265.
3. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977;7:481–493.
4. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty year follow up of the Whickham survey. Clin Endocrinol 1995;43:55–68.
5. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534.
6. Nickerson JF, Hill SR Jr, McNeil JH. Fatal myxedema, with and without coma. Ann Intern Med1960;53:475–493.
7. Gull WW. On a cretinoid state supervening in women in adult life. Trans Clin Soc London1874;7:180–185.
8. Ord WM. On myxoedema, a term proposed to be applied to an essential condition in the cretinoid affection occasionally observed in middle aged women. Med Chir Trans 1878;61:57–78.
9. Ord WM. Report of a committee of the Clinical Society of London nominated December 14, 1883 to investigate the subject of myxoedema. Trans Clin Soc Lond 1888;298–300.
10. Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987;258:209–213.
11. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348:2646–2655.
12. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on TSH, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med1992;92:631–641.
13. Wiersinga WM. Hypothyroidism and myxedema coma, in Degroot LJ, Jameson JL (eds):Endocrinology. Philadelphia, Saunders, 2001, ed 4, 1491–1506.
14. Chiu AC, Sherman SI. Clinical manifestations and differential diagnosis of hypothyroidism, in Falk SA (ed):Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Philadelphia, Lippincott-Raven, 1997, ed 2, pp. 379–391.
15. Heymann WR, Klein A, Ingbar DH, et al. Organ system manifestations of hypothyroidism, in: Braverman LE, Utiger RD [eds], The Thyroid: A Fundamental and Clinical Text. Philadelphia, Lippincott, Williams, and Wilkins, 2000, ed 8, 774–847.
16. Zulewski H, Muller B, Exer P, et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab1997;82:771–776.
17. Hueston WJ. Treatment of hypothyroidism. Am Fam Physician 2001;64:1717–1724.
18. Carpenter CCJ, Solomon N, Silverberg SG et al. Schmidt's syndrome (thyroid and adrenal insufficiency): a review of the literature and a report of fifteen new cases including ten instances of co-existent diabetes mellitus. Medicine 1964;43:153–180.
19. Graves L III, Klein RM, Walling AD. Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome. So Med J 2003;96:824–827.
20. Horak HA, Pourmand R. Endocrine myopathies. Neurol Clin 2000;18:203–213.
21. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocrin Rev2001;22:605–630.
22. Laycock M, Pascuzzi R. The neuromuscular effects of hypothyroidism. Semin Neurol 1991;11:288–294.
23. Diekman T, Lansberg PJ, Kastelein JJP, et al. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995;155:1490–1495.
24. Rader DJ, Rosas S. Hypertriglyceridemia, low HDL cholesterol, lipoprotein (a), in thyroid and renal diseases and posttransplantation. Med Clin N Am 2000;84:43–61.
25. Das KC, Mukherjee M, Sarkar TK, et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 1975;40:211–220.
26. Klein I. Clinical, metabolic, and organ-specific indices of thyroid function. Endocrin Metab Clinics2001;30:415–428.
27. Nicoloff JT, LoPresti JS. Myxedema coma: a form of decompensated hypothyroidism. Endocrin Metabol Clin N Am 1993;22:279–291.
28. Jordan RM. Myxedema coma: pathophysiology, therapy, and factors affecting prognosis. Med Clin N Am 1995;79:185–194.
29. Olsen CG. Myxedema coma in the elderly. J Am Bd Fam Pract 1995;8:376–382.
30. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician 2000;62:2485–2490.
31. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489–499.
32. Geelhoed GW. Metabolic maladaptation: individual and social consequences of medical intervention in correcting endemic hypothyroidism. Nutrition 1999;15:908–932.
33. DeGroot LJ, Larsen PR, Hennemann G. The Thyroid and Its Diseases. New York, Churchill Livingstone, 1996, ed 6, p 347.